PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 15, 2024Open Access

Supplementary Data1 from One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication

View Full Paper
Ask AI
Bookmark
Share

Authors

SWSteven P. WolfVAVasiliki AnastasopoulouKDKimberley Drousch

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wolf et al. (2024) studied this question.

synapsesocial.com/papers/68e6f2a2b6db64358766d0f7https://doi.org/10.1158/1078-0432.25603716.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Supplementary Data1 from One CD4<sup>+</sup>TCR and One CD8<sup>+</sup>TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication2024
  2. 2Data from One CD4<sup>+</sup>TCR and One CD8<sup>+</sup>TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication2024
  3. 3Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-mediated tumor killing from JAK-signaling in melanoma2024
  4. 4Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-mediated tumor killing from JAK-signaling in melanoma2024
  5. 5Supplementary Figure 8 from CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool2024